Weight loss drugs like Ozempic, while transformative in combating obesity, have been linked to irreversible vision impairment ...
Sabellico pictured the first month he was on Ozempic. He lost around five pounds ... After eight weeks on a dose of 1.5 mg, he was down five pounds. But then he woke up one morning and couldn ...
Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year ...
A US resident lost around 40 kilos using a weight-loss drug but developed vision problems, to be ultimately diagnosed with ...
CagriSema, which is a combination of cagrilintide 2.4-milligram and semaglutide 2.4-mg doses, is being developed so people have a better choice for a weight-loss drug when the patents on Ozempic and ...
Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate ...
Vivani Medical completed enrollment in its LIBERATE-1 trial, testing a six-month GLP-1 implant for weight management.
New research has identified cannabis-derived terpenes—compounds that give plants their distinctive aroma—as effective ...
Novo Nordisk announced launching a direct-to-patient online pharmacy NovoCare, offering a more than half-price cut for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback